Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dale Bixby

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 15, 2016
Impact of antibacterial prophylaxis during reinduction chemotherapy for relapse/refractory acute myeloid leukemiaBeejal R Ganti, Bernard L Marini, Jerod Nagel, et al.
International Journal of Molecular Sciences|August 12, 2023
T-Cell Prolymphocytic Leukemia: Diagnosis, Pathogenesis, and TreatmentMarc Gutierrez, Patrick Bladek, Busra Goksu, et al.
The Journal of Infectious Diseases|April 5, 2013
CD133+ hematopoietic progenitor cells harbor HIV genomes in a subset of optimally treated people with long-term viral suppressionLucy A McNamara, Adewunmi Onafuwa-Nuga, Nadia T Sebastian, et al.
Blood|April 21, 2010
Multiple distinct molecular mechanisms influence sensitivity and resistance to MDM2 inhibitors in adult acute myelogenous leukemiaJianting Long, Brian Parkin, Peter Ouillette, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 5, 2022
Hematopoietic Stem and Progenitor Cells (HSPCs)Valeri H Terry, Gretchen E Zimmerman, Maria C Virgilio, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|June 2, 2021
Real world use of FLT3 inhibitors for treatment of FLT3+ acute myeloid leukemia (AML): A single center, propensity-score matched, retrospective cohort studyBrian G Bazzell, Bernard L Marini, Lydia L Benitez, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 17, 2021
Clinical Availability of ATRA for Patients With Suspected Acute Promyelocytic Leukemia: Why Guidelines May Not Be FollowedMarcus J Geer, Charles E Foucar, Sumana Devata, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 13, 2019
Lenalidomide Plus Hypomethylating Agent as a Treatment Option in Acute Myeloid Leukemia With Recurrent Genetic Abnormalities-AML With inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOMLauren E Merz, Anthony J Perissinotti, Bernard L Marini, et al.
Leukemia & Lymphoma|July 19, 2017
PEGging down risk factors for peg-asparaginase hepatotoxicity in patients with acute lymphoblastic leukemia <sup>†</sup>Caitlin R Rausch, Bernard L Marini, Lydia L Benitez, et al.
Nature Medicine|March 9, 2010
HIV-1 infects multipotent progenitor cells causing cell death and establishing latent cellular reservoirsChristoph C Carter, Adewunmi Onafuwa-Nuga, Lucy A McNamara, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 15, 2016
Impact of antibacterial prophylaxis during reinduction chemotherapy for relapse/refractory acute myeloid leukemiaBeejal R Ganti, Bernard L Marini, Jerod Nagel, et al.
International Journal of Molecular Sciences|August 12, 2023
T-Cell Prolymphocytic Leukemia: Diagnosis, Pathogenesis, and TreatmentMarc Gutierrez, Patrick Bladek, Busra Goksu, et al.
The Journal of Infectious Diseases|April 5, 2013
CD133+ hematopoietic progenitor cells harbor HIV genomes in a subset of optimally treated people with long-term viral suppressionLucy A McNamara, Adewunmi Onafuwa-Nuga, Nadia T Sebastian, et al.
Blood|April 21, 2010
Multiple distinct molecular mechanisms influence sensitivity and resistance to MDM2 inhibitors in adult acute myelogenous leukemiaJianting Long, Brian Parkin, Peter Ouillette, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 5, 2022
Hematopoietic Stem and Progenitor Cells (HSPCs)Valeri H Terry, Gretchen E Zimmerman, Maria C Virgilio, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|June 2, 2021
Real world use of FLT3 inhibitors for treatment of FLT3+ acute myeloid leukemia (AML): A single center, propensity-score matched, retrospective cohort studyBrian G Bazzell, Bernard L Marini, Lydia L Benitez, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 17, 2021
Clinical Availability of ATRA for Patients With Suspected Acute Promyelocytic Leukemia: Why Guidelines May Not Be FollowedMarcus J Geer, Charles E Foucar, Sumana Devata, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 13, 2019
Lenalidomide Plus Hypomethylating Agent as a Treatment Option in Acute Myeloid Leukemia With Recurrent Genetic Abnormalities-AML With inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOMLauren E Merz, Anthony J Perissinotti, Bernard L Marini, et al.
Leukemia & Lymphoma|July 19, 2017
PEGging down risk factors for peg-asparaginase hepatotoxicity in patients with acute lymphoblastic leukemia <sup>†</sup>Caitlin R Rausch, Bernard L Marini, Lydia L Benitez, et al.
Nature Medicine|March 9, 2010
HIV-1 infects multipotent progenitor cells causing cell death and establishing latent cellular reservoirsChristoph C Carter, Adewunmi Onafuwa-Nuga, Lucy A McNamara, et al.
Pageof 5